Genorsco

Closed
Call
Website
767 Concord Ave
Cambridge, MA 02138
+1 (617) 494-1460
https://www.genosco.com

Genosco, a Boston-based clinical stage biotech, specializes in discovering and developing novel kinase inhibitors to address unmet medical needs. Their experienced team focuses on kinase targeted therapies, leveraging the proprietary G-SMART™ platform to identify rare sequences and generate highly selective compounds swiftly.

With a strong and diverse pipeline, including independent and partnered programs, Genosco boasts a proven track record supported by successful out-licensing partnerships. The G-SMART™ Platform stands out for mapping over 470 ATP binding sites of human kinases and maintaining a chemical library of 3,500+ master scaffolds for predictive modeling.

Unified under a shared vision to enhance patients' quality of life, Genosco emphasizes strengthening their discovery platform through cutting-edge science. CEO John Koh advocates for fostering an open and positive work environment where employees can unleash their creativity fully, ensuring continued innovation in the field of kinase inhibitors.

Generated from the website content

Also at this address

Own this business?
See a problem?

You might also like

Commercial research laboratory

Cambridge Biomedical Inc

BioAgilytix is a leading bioanalytical laboratory with state-of-the-art facilities in key biotech hubs across the United States, Europe, and Australia. Specializing in large molecule bioanalysis, they offer premier services that support all phases of drug development, from discovery to clinical trials. Their advanced laboratories combine specialized expertise, cutting-edge technology, and deep regulatory knowledge to accelerate global clinical studies. With a focus on delivering high-quality bioanalytical and diagnostic testing services, BioAgilytix is dedicated to enabling the breakthroughs of tomorrow today.Generated from the website
Ambergen Inc
Body shop, trucks, Body shop, automotive, Services, nec, nec

Ambergen Inc

AmberGen Inc., based in Watertown, MA, specializes in next-generation spatial biology through its innovative Miralys technology, which enhances mass spectrometry imaging capabilities. The company's patented solutions enable researchers to explore a wide array of biomolecules, including proteins, lipids, and small molecules, all within the same tissue sample for comprehensive multiomic analysis. With services provided through their MaxOmic Laboratory, AmberGen offers advanced imaging and analysis techniques that facilitate the investigation of diseases by generating deep biological insights swiftly. Their Miralys product line, which includes probes, panels, and antibody conjugation kits, is designed to empower researchers and drug developers in tackling significant questions in biology and medicine. Generated from the website
Commercial research laboratory, Biological research

Vedanta Biosciences, Inc

Vedanta Biosciences, Inc., based in Cambridge, MA, is at the forefront of developing first-in-class Live Biotherapeutic Products (LBPs) to address serious gastrointestinal diseases through the strategic use of defined bacterial consortia. The company is focused on advancing innovative treatments for conditions such as inflammatory bowel disease and recurrent Clostridium difficile infections, with ongoing clinical trials to evaluate the efficacy and safety of its drug candidates. Committed to improving patient outcomes, Vedanta emphasizes the importance of gut health and the role of dysbiosis in gastrointestinal disorders. Through a robust scientific framework, the company leverages its expertise in immune response stimulation and microbial therapies to usher in a new era of gastrointestinal health management. Generated from the website
United States›Massachusetts›Cambridge›Genorsco

Partial Data by Foursquare.